SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending amid community excitement around staking vaults and upcoming updates, including articles covering Trump's Asia tour. Community members are actively discussing the potential for altcoins and the project's roadmap, while some users are skeptical and labeling it a scam. The coin is also associated with meme culture and references to community wealth.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as community members rally around the revival of OG memes and the project's growing "cult." The community emphasizes the project's potential and encourages others to join the movement. There is also growing anticipation of a Moonshot.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending due to discussions surrounding its recent Q3 earnings, which revealed a large increase in operating earnings and a record cash reserve. Investors are actively debating how the company will deploy this capital amid speculation of potential acquisitions and portfolio adjustments. The community is also focused on Warren Buffetts upcoming CEO handover and Berkshire's potential AI investments.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as the community rallies around the tokenization of Satoshi Nakamoto, viewing it as the ultimate narrative and the 'Bitcoin of memes'. Token holders express excitement about upcoming initiatives and see it as a way to honor the legendary figure while paving the path for financial freedom.

Berkshire Hathaway Inc. - Ordinary Shares - Class A

Berkshire Hathaway is trending due to Q3 earnings revealing a massive cash reserve, sparking community discussion on potential acquisitions and investment strategies. Some are looking to Greg Abel's strategic direction, particularly regarding AI and energy initiatives. The community is also reacting to the large cash position and lack of buybacks.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending as the community debates its potential following recent developments, including the upcoming launch of Caffeine AI; some view it as a game-changer, while others are skeptical of its impact on adoption and price action. The conversation also highlights concerns about tokenomics, market manipulation, and whether ICP can compete with established platforms and AI technologies, with some suggesting a change in leadership or increased marketing efforts.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

DASH is experiencing a surge in interest, with community members pointing to past bull cycles and speculating on potential catalysts. Conversations highlight the possibility of DASH catching up to other privacy coins like ZEC and XMR, with some expecting a significant price increase. Bullish sentiment is fueled by discussions around DASH's low supply and potential for adoption.

The Graph is an indexing protocol and global API for organizing blockchain data and making it easily accessible with GraphQL. Developers can use Graph Explorer to search, find, and publish all the public data they need to build decentralized applications. The Graph Network makes it possible to build serverless dApps that run entirely on public infrastructure.  GRT is the native token of the network that’s used to coordinate work. GRT is an ERC20 token. Node operators, called Indexers, stake and earn GRT for processing queries. Anyone can delegate GRT to Indexers to secure the network and earn rewards. Curators organize data on The Graph by signaling GRT on useful APIs, called subgraphs. Indexers, Delegators, and Curators work together to organize the data for the crypto economy and maintain a useful global API for DeFi and Web3.

The Graph

The Graph (GRT) is trending as community members discuss its potential for a significant rise, fueled by mentions of the project's involvement in upcoming events like Smartcon and its relevance to AI. While some express excitement and anticipate substantial gains, others remain skeptical about its near-term prospects, pointing to past performance.

What is the project about?   Horizen is a modular privacy-first platform designed to make privacy technology, such as zero-knowledge proofs and TEEs accessible and usable across the web. Originally launched in 2017 as a fair launch, non-ICO project, Horizen is now undergoing a major evolution with the launch of Horizen 2.0, a next-generation Layer 3 (L3) appchain deployed on Base, the Ethereum Layer 2 developed by Coinbase.  Horizen 2.0 is built as an Ethereum-aligned Layer 3 appchain on Base, inheriting Ethereum's security while implementing its own application-level integrity guarantees.    Key components of Horizen’s security model include:  Ethereum-Aligned Security: As an appchain deployed on Base, Horizen 2.0 benefits from Base’s rollup security and settlement on Ethereum, ensuring robust finality and composability with other L2 and L3 applications.  Simplified and Secure Architecture: Unlike Horizen’s previous iterations (which used a hybrid PoW/PoS model), Horizen 2.0 focuses on application-level security, decentralization of its privacy layers, and composability with existing infrastructure — reducing complexity and increasing user safety.  Decentralized Privacy Stack: Horizen’s focus on decentralizing privacy infrastructure (e.g., decentralized proof generation) allows for modular, secure applications that uphold data confidentiality without compromising performance.    What makes your project unique?  Privacy-first Approach: Horizen integrates a diverse stack of privacy-enhancing technologies (PETs) — including zero-knowledge proofs (ZKPs), trusted execution environments (TEEs), attribute-based encryption (ABE), multi-party computation (MPC), and fully homomorphic encryption (FHE) — to deliver scalable, flexible, and future-ready privacy solutions across its platform.  First Privacy Appchain on Base: As an L3 on Base, Horizen benefits from Ethereum’s security and Base’s scalability, while enabling a privacy layer for any app on the network. This unlocks new possibilities for private identity, DeFi, onchain gaming, and compliant confidential transactions.  Zero-Knowledge, Without the Trade-Offs: Horizen 2.0 scales ZK privacy and verification by integrating with leading zk infrastructure providers such as Fermah, zkVerify, and Singularity, optimizing proof generation for performance, cost-efficiency, and developer usability.  Token Utility Expansion: ZEN’s updated tokenomics allocates 5 million unminted tokens toward strategic ecosystem growth. ZEN powers DAO governance, serves as a payment token in privacy apps, and supports a sustainability fund to accelerate privacy innovation.  Developer-Centric Design: With EVM compatibility, privacy-friendly tooling, and the ability to embed privacy directly into smart contracts, Horizen allows developers to build privacy-first apps without requiring deep cryptographic expertise.  DAO-Led Governance: Governed by the Horizen DAO and shaped through community proposals (ZENIPs), Horizen is evolving as a fully decentralized protocol with transparent development and decision-making.    What can your coin/token be used for?  Horizen 2.0 delivers performance, privacy, and scalability for developers building privacy-enabled and compliance-friendly applications, with significantly reduced cost and latency.  At the core of the ecosystem is ZEN, the native utility token used for governance, accessing privacy services, and fueling zkApp interactions. With its migration to Base, ZEN becomes an ERC-20 token, improving liquidity, interoperability, and composability across the broader Ethereum ecosystem.

ZenCash

ZEN Crypto is trending as traders discuss its potential, particularly its connection to privacy and recent integrations. Community members are weighing in on the coin's relationship to similar cryptos and speculating on future price movement. The migration to Base and halving event is generating additional interest.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot (DOT) is trending amid mixed community sentiment, with some investors expressing frustration over its performance during the current bull run, while others remain optimistic about its staking rewards and long-term potential. Discussions are centered on whether DOT can recapture previous highs, with some speculating on possible catalysts like potential ETF listings or the rumored TikTok deal, while others point to a lack of intrinsic value and questionable tokenomics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know  

Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.

Strength Seen in Moderna (MRNA): Can Its 13.9% Jump Turn into More Strength?

Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

<ul class="summary-bullets"><li>A takeover or a large partnership was reportedly on the table for the company.</li><li>According to a report from Seeking Alpha, citing Stat News, the nature of the potential agreement, while unclear, is one of “significant scope.”&nbsp;</li><li>Moderna has been seeking to expand its portfolio since COVID-19 infections dropped globally. &nbsp;</li></ul>Shares of Moderna (MRNA) jumped 17% on Thursday afternoon following reports that the company held talks with at least one large drugmaker.According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://seekingalpha.com/news/4511489-moderna-gains-on-report-it-held-talks-with-at-least-one-large-drugmaker">report</a> from Seeking Alpha, citing Stat News, a takeover or a large partnership was being considered for the company. The nature of the potential agreement, while unclear, is one of “significant scope,” the report added. &nbsp;<h2 class="st-heading-2">Moderna’s Weakening Sales</h2>In August, the vaccine maker lowered its full-year revenue guidance to a range of $1.5 billion to $2.2 billion, reflecting a $300 million reduction at the high end of the range.For the second quarter, the company reported revenues of $142 million, down from the $241 million reported in the corresponding quarter of 2024. The company attributed the revenue drop to lower COVID-19 vaccine sales. It noted that its demand is expected to be concentrated in the second half of the year, aligning with the fall and winter seasons, due to the seasonal nature of the infection.Sales of Moderna’s COVID-19 vaccine came in at $114 million in the three months through the end of June, while its Respiratory Syncytial Virus vaccine sales were negligible.The company has been seeking to expand its portfolio since COVID-19 infections dropped globally from their peak in the early 2020s. The company hit a peak yearly revenue of $19.3 billion in 2022, when COVID-19 &nbsp;infections were high, which then dropped to $3.2 billion in 2024. The shares have borne the brunt, dropping over 57% in the past five years.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment about <a href="https://stocktwits.com/symbol/MRNA">MRNA stock</a> jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.A Stocktwits user sounded cautious about the company’s upcoming earnings.<stembedurl>https://stocktwits.com/Galba/message/634362215</stembedurl>Since the start of the year, the company’s shares have declined by approximately 30%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/bmy-ceo-expects-cancer-drug-opdivo-to-drive-strong-sales-in-2025/cLG8bFRR3xp">BMY CEO Expects Cancer Drug Opdivo To Drive Strong Sales In 2025</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. (Photo by: Plexi Images/GHI/UCG/Universal Images Group via Getty Images)

Moderna Stock Rallies On Reports Of Company Entering Talks With A Drugmaker For A Potential Deal

According to a report from Seeking Alpha, citing Stat News, Moderna has held talks with at least one large drugmaker. 

Equity

Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline

Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

mRNA Vaccine For Birth Defects Didn't Work Well, Won't Be Continued: Moderna

mRNA Vaccine For Birth Defects Didn't Work Well, Won't Be Continued: Moderna Moderna - which has been around less than 10 years and 'somehow' convinced the government to mandate their mRNA jabs for...

Wall Street's top analyst calls for the week of October 20, 2024

Yahoo Finance looks at Wall Street's top analyst call for the week of October 20, 2024. 0:00 Ebay, Deckers Outdoor, Intel October 24, 2025 1:37 Tesla, Zions Bancorp, Moderna October 23, 2025 3:25...

Moderna (MRNA) Outperforms Broader Market: What You Need to Know

Moderna (MRNA) reached $26.74 at the closing of the latest trading day, reflecting a +1.87% change compared to its last close.

<ul class="summary-bullets"><li>Moderna said its cytomegalovirus (CMV) vaccine, mRNA-1647, failed to prevent infection in women of childbearing age in a large Phase 3 trial, prompting the company to end its congenital CMV program.</li><li>The biotech will continue testing the vaccine in bone marrow transplant patients, where CMV reactivation can cause serious complications, and said no safety concerns were identified.</li><li>Moderna reaffirmed its 2025 guidance and breakeven goal for 2028, noting the vaccine was expected to be cash-flow negative that year.</li></ul>Moderna Inc. shares fell 4% in after-hours trading on Wednesday after the biotech company said its investigational cytomegalovirus (CMV) vaccine, mRNA-1647, failed to meet its primary efficacy endpoint in a late-stage trial.<h2 class="st-heading-2">Phase 3 Trial Misses Target</h2>The Phase 3 trial was designed to determine if the vaccine can prevent CMV infection among seronegative women aged 16-40. Moderna stated that the vaccine efficacy was substantially below the company's expectations and fell between 6 and 23% depending on the case definition used. The company will not continue the development of mRNA-1647 for the prevention of congenital CMV.“Today's announcement is disappointing for families and healthcare professionals who have been eagerly awaiting a CMV vaccine to prevent congenital CMV,” said CEO Stephane Bancel in a statement. “We will share full results with the scientific community in hopes that our learnings contribute to the continued pursuit of a CMV vaccine.”<h2 class="st-heading-2">Focus Shifts To Transplant Patients</h2>Moderna will further evaluate mRNA-1647 in a Phase 2 trial for bone marrow transplant recipients, who can experience serious complications when CMV is reactivated. The company said it will investigate the vaccine’s ability to suppress CMV reactivation in this high-risk population.The company said mRNA-1647 was well-tolerated with no safety concerns identified by the trial’s monitoring board.<h2 class="st-heading-2">No Impact On Financial Outlook</h2>Moderna said the setback is not expected to impact its 2025 financial guidance or its path to breakeven in 2028. The company had expected low revenue for the CMV vaccine in the near term before investments in the market and for the product to be cash-flow negative in 2028.<h2 class="st-heading-2">Stocktwits Users Debate Cash Burn, Oncology Focus After Vaccine Failure</h2>On Stocktwits, retail sentiment for Moderna was ‘bearish’ amid ‘normal’ message volume.<figure class="image"><img style="aspect-ratio:978/137;" src="https://news.stocktwits-cdn.com/mrna_ss_jpg_45aec4f522.webp" alt="mrna ss.jpg" width="978" height="137"><figcaption>MRNA sentiment and message volume as of October 22 | Source: Stocktwits</figcaption></figure>One user suggested the company’s decision to discontinue the CMV program might actually help reduce its cash burn, saying the move could allow Moderna to concentrate more effectively on its oncology pipeline.<stembedurl>https://stocktwits.com/pfh_investing/message/633326630</stembedurl>Another user expressed concern that the company’s spending remained unsustainable, describing its cash burn as “endless.”<stembedurl>https://stocktwits.com/KK_KK/message/633344767</stembedurl>A third bearish user took a harsher view, warning that the stock could fall below $5, after revealing they held two sold naked calls expiring this week.<stembedurl>https://stocktwits.com/georgeyann/message/633359261</stembedurl><a href="https://stocktwits.com/symbol/MRNA">Moderna’s stock</a> has declined 35% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Moderna Stock Slides After-Hours On CMV Vaccine Failure In Phase 3 Trial — Retail Traders Warn Of ‘Endless’ Cash Burn

The biotech will continue testing the vaccine in bone marrow transplant patients, where CMV reactivation can cause serious complications, and said no safety concerns were identified.

Market Wrap- Top Stocks: Tesla, Intuitive Surgical

The earnings season has sent the market into a scramble. Strong reports from major banks last week sent the market soaring, followed by Tuesday's estimate miss from Netflix and electric-vehicle...

Moderna (MRNA) Dips More Than Broader Market: What You Should Know

Moderna (MRNA) closed at $26.85 in the latest trading session, marking a -2.33% move from the prior day.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

MRNA
Moderna Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MRNA News

MRNAModerna Inc